Rosenberg of the national cancer institute and their colleagues independently identified melanoma - specific antigens that are currently being targeted in a variety of clinical trials involving humans 1990年代初期,比利时布鲁塞尔卢特维格癌症中心的布恩、美国国家癌症研究院的罗森柏格其同事,分别找到黑色素瘤特有的抗原,目前已有好几个针对这种抗原的人体临床实验正在进行。